Tej joined Delos Capital as a Partner in 2024. At Delos, Tej identifies and evaluates life sciences companies and draws on his operating experience to support our portfolio.
Prior to Delos, Tej was an Operating Partner at Flagship Pioneering where he was responsible for supporting various biotech companies with their strategy, financing, scientific and broader company build. During his tenure, he supported Laronde (now Sail), where he was Chief Operating Officer; Senda, where he was a board observer, Ring therapeutics, and Harbinger Health. Before Flagship, Tej spent nearly seven years at Moderna Therapeutics in roles of increasing responsibility concluding as Senior Vice President overseeing the clinical portfolio. He also helped build their early preclinical and clinical manufacturing and helped take the company public. He joined Moderna from McKinsey & Company where he was an Engagement Manager in the biopharmaceutical practice. He started his career in preclinical development of biologics at Merck.
Tej has a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison, USA and his Bachelor’s in Chemical Engineering from the University Institute of Chemical Technology, Mumbai, India.